StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.78+0.08 (+2.16%)

Close on Nov 18, 2026Market cap $474.43MP/E –Yield –

Aquestive Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Aquestive Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $54.09M, up 22.6% year over year. For fiscal 2025 it was $44.55M, down 22.6% from the year before. The highest annual figure on record is $67.43M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.55M-22.6%
FY2024Dec 31, 2024$57.56M+13.8%
FY2023Dec 31, 2023$50.58M+6.1%
FY2022Dec 31, 2022$47.68M-6.2%
FY2021Dec 31, 2021$50.83M+10.9%
FY2020Dec 31, 2020$45.85M-12.8%
FY2019Dec 31, 2019$52.61M-22.0%
FY2018Dec 31, 2018$67.43M+0.8%
FY2017Dec 31, 2017$66.92M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$13.82M+38.1%
Q1 FY2026Mar 31, 2026$14.45M+65.7%
Q4 FY2025Dec 31, 2025$13.02M+9.7%
Q3 FY2025Sep 30, 2025$12.81M-5.4%
Q2 FY2025Jun 30, 2025$10.00M-50.2%
Q1 FY2025Mar 31, 2025$8.72M-27.7%
Q4 FY2024Dec 31, 2024$11.87M-10.1%
Q3 FY2024Sep 30, 2024$13.54M+4.2%
Q2 FY2024Jun 30, 2024$20.10M+51.8%
Q1 FY2024Mar 31, 2024$12.05M+8.3%
Q4 FY2023Dec 31, 2023$13.21M+23.6%
Q3 FY2023Sep 30, 2023$13.00M+13.4%
Q2 FY2023Jun 30, 2023$13.24M-0.2%
Q1 FY2023Mar 31, 2023$11.13M-9.3%
Q4 FY2022Dec 31, 2022$10.68M-3.6%
Q3 FY2022Sep 30, 2022$11.46M-13.7%
Q2 FY2022Jun 30, 2022$13.27M-13.6%
Q1 FY2022Mar 31, 2022$12.27M+10.3%
Q4 FY2021Dec 31, 2021$11.08M+55.0%
Q3 FY2021Sep 30, 2021$13.29M+60.9%
Q2 FY2021Jun 30, 2021$15.35M-29.2%
Q1 FY2021Mar 31, 2021$11.12M+26.9%
Q4 FY2020Dec 31, 2020$7.15M-56.5%
Q3 FY2020Sep 30, 2020$8.26M-33.5%
Q2 FY2020Jun 30, 2020$21.68M+94.8%
Q1 FY2020Mar 31, 2020$8.77M-30.7%
Q4 FY2019Dec 31, 2019$16.42M-2.4%
Q3 FY2019Sep 30, 2019$12.42M-47.0%
Q2 FY2019Jun 30, 2019$11.13M-8.7%
Q1 FY2019Mar 31, 2019$12.64M-53.4%
Q4 FY2018Dec 31, 2018$16.82M+51.0%
Q1 FY2018Mar 31, 2018$23.41M+42.4%
Q4 FY2017Dec 31, 2017$12.19M–
Q3 FY2017Sep 30, 2017$27.15M–
Q2 FY2017Jun 30, 2017$11.14M–
Q1 FY2017Mar 31, 2017$16.44M–

More Aquestive Therapeutics figures

See a number that looks wrong?